Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.
- Market Cap ₹ 471 Cr.
- Current Price ₹ 236
- High / Low ₹ 283 / 85.0
- Stock P/E 8.63
- Book Value ₹ 170
- Dividend Yield 0.64 %
- ROCE 21.8 %
- ROE 17.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 27.92% CAGR over last 5 years
Cons
- The company has delivered a poor growth of 10.99% over past five years.
- Promoter holding is low: 33.41%
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
76 | 72 | 97 | 98 | 81 | 77 | 95 | 111 | 96 | 75 | 101 | 122 | |
61 | 64 | 75 | 82 | 68 | 68 | 77 | 88 | 84 | 68 | 81 | 94 | |
Operating Profit | 15 | 8 | 22 | 16 | 13 | 10 | 17 | 23 | 12 | 8 | 20 | 28 |
OPM % | 19% | 12% | 22% | 16% | 16% | 12% | 18% | 20% | 12% | 10% | 20% | 23% |
Other Income | 3 | 2 | 2 | 4 | 1 | -1 | 2 | 3 | 2 | 5 | 2 | 1 |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit before tax | 16 | 8 | 22 | 18 | 11 | 7 | 17 | 24 | 12 | 11 | 21 | 27 |
Tax % | 28% | 8% | 29% | 20% | 16% | -3% | 28% | 24% | 16% | 19% | 27% | 26% |
Net Profit | 11 | 7 | 16 | 14 | 9 | 7 | 12 | 18 | 10 | 9 | 15 | 20 |
EPS in Rs | 5.56 | 3.60 | 7.80 | 7.20 | 4.72 | 3.59 | 6.08 | 9.00 | 5.09 | 4.62 | 7.50 | 10.10 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
114 | 121 | 165 | 175 | 192 | 208 | 223 | 311 | 304 | 325 | 353 | 376 | 394 | |
104 | 111 | 156 | 161 | 176 | 190 | 200 | 278 | 261 | 279 | 292 | 317 | 327 | |
Operating Profit | 10 | 11 | 9 | 13 | 16 | 19 | 23 | 33 | 43 | 46 | 61 | 59 | 68 |
OPM % | 9% | 9% | 6% | 8% | 8% | 9% | 10% | 11% | 14% | 14% | 17% | 16% | 17% |
Other Income | -1 | 1 | 3 | 3 | 5 | 1 | 5 | 6 | 2 | 6 | 6 | 12 | 11 |
Interest | 2 | 3 | 5 | 8 | 7 | 5 | 6 | 6 | 5 | 4 | 4 | 2 | 1 |
Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 6 |
Profit before tax | 7 | 8 | 6 | 7 | 11 | 13 | 19 | 30 | 36 | 43 | 58 | 64 | 72 |
Tax % | 35% | 28% | 32% | 31% | 13% | 9% | 23% | 28% | 23% | 24% | 20% | 23% | |
Net Profit | 4 | 6 | 4 | 5 | 10 | 11 | 15 | 22 | 27 | 33 | 47 | 50 | 55 |
EPS in Rs | 5.10 | 2.47 | 3.05 | 6.01 | 7.01 | 9.06 | 13.33 | 13.70 | 16.38 | 23.32 | 24.78 | 27.31 | |
Dividend Payout % | 21% | 24% | 24% | 20% | 10% | 9% | 11% | 8% | 9% | 9% | 6% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | 7% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 28% |
3 Years: | 22% |
TTM: | 17% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 6% |
3 Years: | 1% |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 18% |
3 Years: | 18% |
Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | 11 | 16 | 16 | 16 | 16 | 16 | 16 | 20 | 20 | 20 | 20 | 20 | |
Reserves | 28 | 42 | 60 | 64 | 73 | 83 | 95 | 115 | 170 | 200 | 243 | 284 | 319 |
Borrowings | 16 | 27 | 45 | 57 | 61 | 51 | 48 | 61 | 53 | 56 | 34 | 5 | 18 |
22 | 30 | 42 | 60 | 61 | 70 | 32 | 50 | 39 | 50 | 51 | 58 | 69 | |
Total Liabilities | 73 | 110 | 164 | 197 | 211 | 220 | 192 | 242 | 282 | 326 | 347 | 367 | 426 |
17 | 21 | 28 | 33 | 33 | 32 | 33 | 63 | 68 | 83 | 88 | 91 | 89 | |
CWIP | 0 | 1 | 4 | 2 | 2 | 2 | 3 | 3 | 7 | 0 | 2 | 0 | 0 |
Investments | 0 | 0 | 0 | 11 | 11 | 11 | 13 | 20 | 36 | 39 | 46 | 60 | 98 |
56 | 88 | 132 | 151 | 164 | 174 | 143 | 156 | 171 | 204 | 211 | 216 | 239 | |
Total Assets | 73 | 110 | 164 | 197 | 211 | 220 | 192 | 242 | 282 | 326 | 347 | 367 | 426 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | -12 | -34 | 10 | 4 | 9 | 9 | 29 | 18 | 21 | 51 | 71 | |
-4 | -6 | -11 | -17 | -1 | 3 | -5 | -40 | -26 | -14 | -22 | -29 | |
3 | 26 | 45 | 3 | -1 | -17 | -5 | 11 | 8 | -4 | -30 | -38 | |
Net Cash Flow | 1 | 8 | 1 | -4 | 2 | -5 | -1 | -0 | -0 | 4 | -1 | 4 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 19% | 16% | 10% | 10% | 12% | 12% | 16% | 21% | 19% | 18% | 22% | 22% |
Debtor Days | 74 | 94 | 88 | 136 | 139 | 152 | 135 | 88 | 95 | 108 | 117 | 88 |
Inventory Turnover | 5.54 | 3.77 | 4.38 | 4.83 | 6.63 | 7.64 | 7.28 | 9.44 | 6.31 | 5.20 | 5.58 | 5.80 |
Documents
Add documentRecent announcements
- Shareholding for the Period Ended December 31, 2020 11 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 11 Jan
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1 Jan
- Closure of Trading Window 31 Dec
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 29 Dec
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse